• OPEN AN ACCOUNT
Indian Indices
Nifty
25,910.05 30.90
(0.12%)
Sensex
84,562.78 84.11
( 0.10%)
Bank Nifty
58,517.55 135.60
( 0.23%)
Nifty IT
36,301.25 -378.20
( -1.03%)
Global Indices
Nasdaq
47,163.83 -314.39
(-0.66%)
Dow Jones
6,754.35 -4.14
(-0.06%)
Hang Seng
50,333.56 -948.27
(-1.85%)
Nikkei 225
9,693.83 -113.85
(-1.16%)
Forex
USD-INR
88.71 0.12
(0.13%)
EUR-INR
103.04 0.44
(0.43%)
GBP-INR
116.72 0.41
(0.35%)
JPY-INR
0.57 0.00
(0.16%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
411.5600262
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
23.8
123722.28
EPS(TTM)
Face Value()
Div & Yield %
64.35
2
1.04
 

Stanrose Mafatlal Investment & Finance reports consolidated net loss of Rs 0.66 crore in the September 2025 quarter
Nov 04,2025
Net Loss of Stanrose Mafatlal Investment & Finance reported to Rs 0.66 crore in the quarter ended September 2025 as against net loss of Rs 0.29 crore during the previous quarter ended September 2024. Sales declined 26.39% to Rs 0.53 crore in the quarter ended September 2025 as against Rs 0.72 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales0.530.72 -26
OPM %-132.08-22.22 -
PBDT-0.70-0.17 -312
PBT-0.83-0.28 -196
NP-0.66-0.29 -128